Intellia Therapeutics PE Ratio 2015-2024 | NTLA

Current and historical p/e ratio for Intellia Therapeutics (NTLA) from 2015 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Intellia Therapeutics PE ratio as of November 07, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Intellia Therapeutics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-11-06 16.06 0.00
2024-06-30 22.38 $-5.48 0.00
2024-03-31 27.51 $-5.36 0.00
2023-12-31 30.49 $-5.41 0.00
2023-09-30 31.62 $-5.35 0.00
2023-06-30 40.78 $-5.46 0.00
2023-03-31 37.27 $-5.39 0.00
2022-12-31 34.89 $-6.18 0.00
2022-09-30 55.96 $-5.87 0.00
2022-06-30 51.76 $-5.35 0.00
2022-03-31 72.67 $-5.03 0.00
2021-12-31 118.24 $-3.76 0.00
2021-09-30 134.15 $-3.36 0.00
2021-06-30 161.91 $-2.86 0.00
2021-03-31 80.26 $-2.46 0.00
2020-12-31 54.40 $-2.40 0.00
2020-09-30 19.88 $-2.28 0.00
2020-06-30 21.02 $-2.30 0.00
2020-03-31 12.23 $-2.25 0.00
2019-12-31 14.67 $-2.11 0.00
2019-09-30 13.35 $-1.97 0.00
2019-06-30 16.37 $-2.01 0.00
2019-03-31 17.08 $-1.97 0.00
2018-12-31 13.65 $-1.99 0.00
2018-09-30 28.62 $-2.17 0.00
2018-06-30 27.36 $-2.08 0.00
2018-03-31 21.09 $-2.01 0.00
2017-12-31 19.22 $-1.86 0.00
2017-09-30 24.85 $-1.56 0.00
2017-06-30 16.00 $-1.34 0.00
2017-03-31 14.09 $-1.25 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.631B $0.036B
Intellia Therapeutics is a leading clinical-stage genome editing company focused on developing CRISPR/Cas9-based therapeutics. The company is pursuing two primary approaches to fully realize the transformative potential of CRISPR/Cas9 in vivo programs that use intravenously administered CRISPR as the therapy and ex vivo programs that use CRISPR to create the therapy by using engineered human cells.?
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $172.973B 16.74
Vertex Pharmaceuticals (VRTX) United States $127.127B 0.00
Gilead Sciences (GILD) United States $114.153B 20.70
Bristol Myers Squibb (BMY) United States $112.118B 47.25
CSL (CSLLY) Australia $90.953B 0.00
Regeneron Pharmaceuticals (REGN) United States $89.741B 20.43
GSK (GSK) United Kingdom $74.404B 8.61
Argenex SE (ARGX) Netherlands $35.218B 0.00
Alnylam Pharmaceuticals (ALNY) United States $35.213B 0.00
Biogen (BIIB) United States $25.413B 10.91
BioNTech SE (BNTX) Germany $25.355B 0.00
Illumina (ILMN) United States $24.187B 87.76
Moderna (MRNA) United States $19.916B 0.00
BeiGene (BGNE) Cayman Islands $19.734B 0.00
Incyte (INCY) United States $15.595B 0.00
Genmab (GMAB) Denmark $14.777B 21.68
Insmed (INSM) United States $13.035B 0.00
Vaxcyte (PCVX) United States $12.971B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.607B 29.27
Sarepta Therapeutics (SRPT) United States $12.204B 110.32
Bio-Techne Corp (TECH) United States $12.049B 46.52
Exelixis (EXEL) United States $10.141B 23.06
Exact Sciences (EXAS) United States $10.127B 0.00
QIAGEN (QGEN) Netherlands $10.011B 20.60
Revolution Medicines (RVMD) United States $9.925B 0.00
Intra-Cellular Therapies (ITCI) United States $9.482B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
Roivant Sciences (ROIV) United Kingdom $8.689B 0.00
Repligen (RGEN) United States $8.173B 124.73
Ascendis Pharma (ASND) Denmark $7.845B 0.00
Halozyme Therapeutics (HALO) United States $7.714B 17.42
Legend Biotech (LEGN) United States $7.546B 0.00
Viking Therapeutics (VKTX) United States $7.340B 0.00
Cytokinetics (CYTK) United States $6.530B 0.00
Blueprint Medicines (BPMC) United States $6.329B 0.00
Nuvalent (NUVL) United States $6.097B 0.00
Krystal Biotech (KRYS) United States $5.266B 87.19
Avidity Biosciences (RNA) United States $5.187B 0.00
Biohaven (BHVN) United States $5.081B 0.00
Arcellx (ACLX) United States $4.998B 0.00
Alkermes (ALKS) Ireland $4.739B 15.92
Ultragenyx Pharmaceutical (RARE) United States $4.656B 0.00
Immunovant (IMVT) United States $4.599B 0.00
ADMA Biologics Inc (ADMA) United States $4.585B 75.65
CRISPR Therapeutics AG (CRSP) Switzerland $4.329B 0.00
Axsome Therapeutics (AXSM) United States $4.321B 0.00
Denali Therapeutics (DNLI) United States $4.231B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.830B 0.00
ImmunityBio (IBRX) United States $3.775B 0.00
Merus (MRUS) Netherlands $3.637B 0.00
Apellis Pharmaceuticals (APLS) United States $3.586B 0.00
Edgewise Therapeutics (EWTX) United States $3.434B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.405B 0.00
Iovance Biotherapeutics (IOVA) United States $3.397B 0.00
Amicus Therapeutics (FOLD) United States $3.334B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.289B 0.00
Kymera Therapeutics (KYMR) United States $3.205B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.195B 0.00
Guardant Health (GH) United States $3.111B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.054B 0.00
Zai Lab (ZLAB) China $3.018B 0.00
Janux Therapeutics (JANX) United States $2.863B 0.00
Protagonist Therapeutics (PTGX) United States $2.804B 18.17
Twist Bioscience (TWST) United States $2.661B 0.00
Apogee Therapeutics (APGE) United States $2.646B 0.00
Vera Therapeutics (VERA) United States $2.628B 0.00
IDEAYA Biosciences (IDYA) United States $2.628B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.619B 20.24
CG Oncology (CGON) United States $2.595B 0.00
Geron (GERN) United States $2.574B 0.00
Keros Therapeutics (KROS) United States $2.493B 0.00
Belite Bio (BLTE) United States $2.482B 0.00
SpringWorks Therapeutics (SWTX) United States $2.451B 0.00
Akero Therapeutics (AKRO) United States $2.450B 0.00
Scholar Rock Holding (SRRK) United States $2.371B 0.00
Vericel (VCEL) United States $2.355B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.326B 0.00
Bavarian Nordic (BVNRY) Denmark $2.254B 12.06
Beam Therapeutics (BEAM) United States $2.204B 0.00
Structure Therapeutics (GPCR) United States $2.193B 0.00
Ligand Pharmaceuticals (LGND) United States $2.136B 36.30
MannKind (MNKD) United States $2.046B 74.40
Neumora Therapeutics (NMRA) United States $2.034B 0.00
NeoGenomics (NEO) United States $1.984B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.960B 0.00
NovoCure (NVCR) Jersey $1.958B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.956B 16.25
Disc Medicine (IRON) United States $1.926B 0.00
Arvinas (ARVN) United States $1.923B 0.00
Nurix Therapeutics (NRIX) United States $1.913B 0.00
Spyre Therapeutics (SYRE) United States $1.908B 0.00
Celldex Therapeutics (CLDX) United States $1.832B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.822B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.780B 0.00
Galapagos (GLPG) Belgium $1.779B 0.00
WAVE Life Sciences (WVE) Singapore $1.771B 0.00
Certara (CERT) United States $1.755B 49.59
Immunocore Holdings (IMCR) United Kingdom $1.676B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.663B 0.00
Fortrea Holdings (FTRE) United States $1.621B 50.25
Dynavax Technologies (DVAX) United States $1.611B 111.73
Rocket Pharmaceuticals (RCKT) United States $1.600B 0.00
Myriad Genetics (MYGN) United States $1.596B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.556B 0.00
Viridian Therapeutics (VRDN) United States $1.551B 0.00
Gyre Therapeutics (GYRE) United States $1.462B 0.00
Arcus Biosciences (RCUS) United States $1.438B 0.00
Novavax (NVAX) United States $1.434B 0.00
Vir Biotechnology (VIR) United States $1.401B 0.00
Kura Oncology (KURA) United States $1.367B 0.00
Upstream Bio (UPB) United States $1.364B 0.00
Travere Therapeutics (TVTX) United States $1.350B 0.00
Praxis Precision Medicines (PRAX) United States $1.276B 0.00
Bicara Therapeutics (BCAX) United States $1.230B 0.00
ANI Pharmaceuticals (ANIP) United States $1.229B 16.69
ArriVent BioPharma (AVBP) United States $1.172B 0.00
Cogent Biosciences (COGT) United States $1.147B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.129B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.123B 0.00
Applied Therapeutics (APLT) United States $1.108B 0.00
MiMedx (MDXG) United States $1.102B 28.85
Immatics (IMTX) Germany $1.097B 0.00
Septerna (SEPN) $1.076B 0.00
Zymeworks (ZYME) United States $1.075B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.073B 0.00
89BIO (ETNB) United States $1.001B 0.00
Mesoblast (MESO) Australia $0.997B 0.00
Prothena (PRTA) Ireland $0.987B 0.00
CARGO Therapeutics (CRGX) United States $0.976B 0.00
Cytek Biosciences (CTKB) United States $0.973B 0.00
Rapport Therapeutics (RAPP) United States $0.956B 0.00
Cullinan Therapeutics (CGEM) United States $0.955B 0.00
Pliant Therapeutics (PLRX) United States $0.955B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.950B 0.00
Castle Biosciences (CSTL) United States $0.915B 163.30
Tyra Biosciences (TYRA) United States $0.904B 0.00
Erasca (ERAS) United States $0.898B 0.00
LENZ Therapeutics (LENZ) United States $0.886B 0.00
Replimune (REPL) United States $0.868B 0.00
IGM Biosciences (IGMS) United States $0.865B 0.00
Dianthus Therapeutics (DNTH) United States $0.864B 0.00
Adaptive Biotechnologies (ADPT) United States $0.848B 0.00
Neurogene (NGNE) United States $0.830B 0.00
Zenas BioPharma (ZBIO) United States $0.828B 0.00
Liquidia Technologies (LQDA) United States $0.817B 0.00
AbCellera Biologics (ABCL) Canada $0.815B 0.00
Pacira BioSciences (PCRX) United States $0.815B 7.68
Annexon (ANNX) United States $0.789B 0.00
Immunome (IMNM) United States $0.787B 0.00
BioAge Labs (BIOA) United States $0.784B 0.00
Sana Biotechnology (SANA) United States $0.759B 0.00
Mineralys Therapeutics (MLYS) United States $0.743B 0.00
Arbutus Biopharma (ABUS) United States $0.740B 0.00
Oric Pharmaceuticals (ORIC) United States $0.727B 0.00
MBX Biosciences (MBX) United States $0.725B 0.00
Olema Pharmaceuticals (OLMA) United States $0.717B 0.00
Stoke Therapeutics (STOK) United States $0.702B 0.00
Avid Bioservices (CDMO) United States $0.700B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.699B 0.00
Entrada Therapeutics (TRDA) United States $0.698B 11.74
Oculis Holding AG (OCS) Switzerland $0.684B 0.00
AnaptysBio (ANAB) United States $0.676B 0.00
Allogene Therapeutics (ALLO) United States $0.673B 0.00
Astria Therapeutics (ATXS) United States $0.670B 0.00
Tectonic Therapeutic (TECX) United States $0.661B 0.00
Anavex Life Sciences (AVXL) United States $0.661B 0.00
Abivax SA (ABVX) France $0.658B 0.00
Humacyte (HUMA) United States $0.648B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
CureVac (CVAC) Germany $0.640B 0.00
Nuvation Bio (NUVB) United States $0.633B 0.00
CorMedix Inc (CRMD) United States $0.626B 0.00
Revance Therapeutics (RVNC) United States $0.609B 0.00
Celcuity (CELC) United States $0.602B 0.00
ACELYRIN, INC (SLRN) United States $0.599B 0.00
Alumis (ALMS) United States $0.583B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.580B 0.00
Q32 Bio (QTTB) United States $0.579B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.549B 0.00
Aura Biosciences (AURA) United States $0.546B 0.00
Third Harmonic Bio (THRD) United States $0.545B 0.00
Pharming Group (PHAR) Netherlands $0.536B 0.00
ChromaDex (CDXC) United States $0.534B 699.00
Sangamo Therapeutics (SGMO) United States $0.514B 0.00
Foghorn Therapeutics (FHTX) United States $0.514B 0.00
Alector (ALEC) United States $0.510B 0.00
Terns Pharmaceuticals (TERN) United States $0.509B 0.00
PureTech Health (PRTC) United States $0.505B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.494B 0.00
Prime Medicine (PRME) United States $0.492B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.491B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.487B 0.00
Emergent Biosolutions (EBS) United States $0.487B 0.00
Absci (ABSI) United States $0.470B 0.00
REGENXBIO (RGNX) United States $0.466B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.462B 0.00
GH Research (GHRS) Ireland $0.454B 0.00
Cartesian Therapeutics (RNAC) United States $0.446B 0.00
Contineum Therapeutics (CTNM) United States $0.443B 0.00
GRAIL (GRAL) United States $0.429B 0.00
C4 Therapeutics (CCCC) United States $0.421B 0.00
MeiraGTx Holdings (MGTX) United States $0.417B 0.00
MaxCyte (MXCT) United States $0.409B 0.00
Voyager Therapeutics (VYGR) United States $0.397B 26.00
EnGene Holdings (ENGN) Canada $0.388B 0.00
XOMA Royalty (XOMA) United States $0.380B 0.00
Alpha Teknova (TKNO) United States $0.367B 0.00
Nautilus Biotechnology (NAUT) United States $0.363B 0.00
Jasper Therapeutics (JSPR) United States $0.358B 0.00
Artiva Biotherapeutics (ARTV) United States $0.351B 0.00
UniQure (QURE) Netherlands $0.349B 0.00
Tango Therapeutics (TNGX) United States $0.347B 0.00
Kamada (KMDA) Israel $0.344B 22.18
ITeos Therapeutics (ITOS) United States $0.343B 0.00
Sutro Biopharma (STRO) United States $0.339B 0.00
Design Therapeutics (DSGN) United States $0.336B 0.00
Northwest Biotherapeutics (NWBO) United States $0.336B 0.00
Codexis (CDXS) United States $0.326B 0.00
Rezolute (RZLT) United States $0.325B 0.00
Biomea Fusion (BMEA) United States $0.322B 0.00
BioStem Technologies (BSEM) $0.319B 49.26
Fate Therapeutics (FATE) United States $0.318B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.309B 0.00
AC Immune (ACIU) Switzerland $0.306B 0.00
Atea Pharmaceuticals (AVIR) United States $0.302B 0.00
TScan Therapeutics (TCRX) United States $0.301B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.298B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.297B 0.00
Zura Bio (ZURA) United States $0.289B 0.00
Urogen Pharma (URGN) United States $0.287B 0.00
Mersana Therapeutics (MRSN) United States $0.287B 0.00
Ocugen (OCGN) United States $0.286B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.285B 0.00
GENFIT S.A (GNFT) France $0.279B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.273B 0.00
Abeona Therapeutics (ABEO) United States $0.272B 0.00
Inozyme Pharma (INZY) United States $0.272B 0.00
Editas Medicine (EDIT) United States $0.271B 0.00
Poseida Therapeutics (PSTX) United States $0.270B 0.00
Prima BioMed (IMMP) Australia $0.266B 0.00
2seventy Bio (TSVT) United States $0.255B 0.00
Anika Therapeutics (ANIK) United States $0.253B 0.00
Compass Therapeutics (CMPX) United States $0.252B 0.00
XBiotech (XBIT) United States $0.251B 0.00
Kodiak Sciences (KOD) United States $0.250B 0.00
Caribou Biosciences (CRBU) United States $0.249B 0.00
Bright Minds Biosciences (DRUG) United States $0.247B 0.00
ATyr Pharma (ATYR) United States $0.246B 0.00
Climb Bio (CLYM) United States $0.245B 0.00
Opthea (OPT) Australia $0.244B 0.00
Amarin (AMRN) Ireland $0.243B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.241B 0.00
Solid Biosciences (SLDB) United States $0.237B 0.00
Nkarta (NKTX) United States $0.236B 0.00
Lifecore Biomedical (LFCR) United States $0.236B 0.00
PepGen (PEPG) United States $0.234B 0.00
Inhibrx Biosciences (INBX) United States $0.232B 0.00
Molecular Partners AG (MOLN) Switzerland $0.229B 0.00
Cabaletta Bio (CABA) United States $0.227B 0.00
Precigen (PGEN) United States $0.226B 0.00
Trevi Therapeutics (TRVI) United States $0.225B 0.00
Eton Pharmaceuticals (ETON) United States $0.224B 0.00
Semper Paratus Acquisition (TVGN) United States $0.222B 0.00
Kyverna Therapeutics (KYTX) United States $0.221B 0.00
ScPharmaceuticals (SCPH) United States $0.217B 0.00
Fulcrum Therapeutics (FULC) United States $0.214B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.212B 0.00
Scilex Holding (SCLX) United States $0.205B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.201B 0.00
Gossamer Bio (GOSS) United States $0.201B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.194B 0.00
Greenwich LifeSciences (GLSI) United States $0.190B 0.00
Black Diamond Therapeutics (BDTX) United States $0.186B 0.00
DiaMedica Therapeutics (DMAC) United States $0.185B 0.00
Sagimet Biosciences (SGMT) United States $0.184B 0.00
CAMP4 Therapeutics (CAMP) United States $0.178B 0.00
Cardiff Oncology (CRDF) United States $0.177B 0.00
Tenaya Therapeutics (TNYA) United States $0.176B 0.00
Candel Therapeutics (CADL) United States $0.171B 0.00
Actuate Therapeutics (ACTU) United States $0.170B 0.00
Innate Pharma S.A (IPHA) France $0.167B 0.00
Adverum Biotechnologies (ADVM) United States $0.165B 0.00
Ventyx Biosciences (VTYX) United States $0.165B 0.00
Skye Bioscience (SKYE) United States $0.163B 0.00
Instil Bio (TIL) United States $0.161B 0.00
Akoya Biosciences (AKYA) United States $0.160B 0.00
Generation Bio (GBIO) United States $0.160B 0.00
Nuvectis Pharma (NVCT) United States $0.157B 0.00
Verastem (VSTM) United States $0.156B 0.00
Oncobiologics (OTLK) United States $0.154B 0.00
Compugen (CGEN) Israel $0.153B 0.00
Repare Therapeutics (RPTX) Canada $0.153B 0.00
Checkpoint Therapeutics (CKPT) United States $0.152B 0.00
Vigil Neuroscience (VIGL) United States $0.151B 0.00
Puma Biotechnology (PBYI) United States $0.150B 16.10
Inovio Pharmaceuticals (INO) United States $0.147B 0.00
INmune Bio (INMB) United States $0.143B 0.00
Inventiva S.A (IVA) France $0.141B 0.00
Adherex Technologies (FENC) United States $0.136B 123.75
Adagene (ADAG) China $0.135B 0.00
Rani Therapeutics Holdings (RANI) United States $0.132B 0.00
Seres Therapeutics (MCRB) United States $0.129B 0.00
Seer (SEER) United States $0.127B 0.00
FibroBiologics (FBLG) United States $0.126B 0.00
Elutia (ELUT) United States $0.126B 0.00
Allakos (ALLK) United States $0.125B 0.00
Invivyd (IVVD) United States $0.124B 0.00
PDS Biotechnology (PDSB) United States $0.119B 0.00
23andMe Holding (ME) United States $0.117B 0.00
Annovis Bio (ANVS) United States $0.112B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.111B 0.00
Benitec Biopharma (BNTC) United States $0.111B 0.00
Coya Therapeutics (COYA) United States $0.111B 0.00
Adicet Bio (ACET) United States $0.107B 0.00
Werewolf Therapeutics (HOWL) United States $0.107B 0.00
Alto Neuroscience (ANRO) United States $0.106B 0.00
Immunic (IMUX) United States $0.106B 0.00
Genelux (GNLX) United States $0.104B 0.00
Renovaro (RENB) United States $0.101B 0.00
BioAtla (BCAB) United States $0.100B 0.00
Cellectis S.A (CLLS) France $0.098B 0.00
HilleVax (HLVX) United States $0.098B 0.00
X4 Pharmaceuticals (XFOR) United States $0.098B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.095B 0.00
Leap Therapeutics (LPTX) United States $0.095B 0.00
Rapt Therapeutics (RAPT) United States $0.095B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.095B 0.00
Cidara Therapeutics (CDTX) United States $0.093B 0.00
Ovid Therapeutics (OVID) United States $0.092B 0.00
Agenus (AGEN) United States $0.091B 0.00
Genenta Science S.p.A (GNTA) Italy $0.091B 0.00
Chimerix (CMRX) United States $0.091B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.090B 0.00
InflaRx (IFRX) Germany $0.090B 0.00
I-Mab (IMAB) China $0.089B 0.00
Oncolytics Biotech (ONCY) Canada $0.086B 0.00
Adlai Nortye (ANL) Cayman Islands $0.086B 0.00
Bluebird Bio (BLUE) United States $0.085B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.085B 0.00
VistaGen Therapeutics (VTGN) United States $0.084B 0.00
Coherus BioSciences (CHRS) United States $0.083B 0.00
Aileron Therapeutics (ALRN) United States $0.083B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
BioHarvest Sciences (CNVCF) Canada $0.081B 0.00
Clearside Biomedical (CLSD) United States $0.081B 0.00
ALX Oncology Holdings (ALXO) United States $0.081B 0.00
Cue Biopharma (CUE) United States $0.080B 0.00
Aerovate Therapeutics (AVTE) United States $0.080B 0.00
CervoMed (CRVO) United States $0.079B 0.00
CytomX Therapeutics (CTMX) United States $0.078B 7.14
BeyondSpring (BYSI) United States $0.078B 0.00
MediciNova (MNOV) United States $0.077B 0.00
IO Biotech (IOBT) Denmark $0.076B 0.00
TELA Bio (TELA) United States $0.075B 0.00
Galena Biopharma (SLS) United States $0.075B 0.00
DBV Technologies S.A (DBVT) France $0.074B 0.00
Spero Therapeutics (SPRO) United States $0.071B 3.20
Boundless Bio (BOLD) United States $0.071B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
Syros Pharmaceuticals (SYRS) United States $0.066B 0.00
Connect Biopharma Holdings (CNTB) United States $0.065B 0.00
Precision BioSciences (DTIL) United States $0.064B 0.00
Quince Therapeutics (QNCX) United States $0.063B 0.00
Monopar Therapeutics (MNPR) United States $0.063B 0.00
Omega Therapeutics (OMGA) United States $0.062B 0.00
Entera Bio (ENTX) Israel $0.062B 0.00
Enzo Biochem (ENZ) United States $0.059B 0.00
Theratechnologies (THTX) Canada $0.059B 0.00
Vor Biopharma (VOR) $0.059B 0.00
Shattuck Labs (STTK) United States $0.059B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.058B 0.00
Kronos Bio (KRON) United States $0.058B 0.00
Immuneering (IMRX) United States $0.057B 0.00
OnKure Therapeutics (OKUR) United States $0.057B 0.00
Xilio Therapeutics (XLO) United States $0.057B 0.00
Imunon (IMNN) United States $0.056B 0.00
Affimed (AFMD) Germany $0.054B 0.00
Kezar Life Sciences (KZR) United States $0.054B 0.00
Aadi Bioscience (AADI) United States $0.052B 0.00
Elicio Therapeutics (ELTX) United States $0.051B 0.00
Atara Biotherapeutics (ATRA) United States $0.049B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.048B 0.00
HOOKIPA Pharma (HOOK) United States $0.046B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.045B 0.00
Intensity Therapeutics (INTS) United States $0.045B 0.00
Immix Biopharma (IMMX) United States $0.044B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.043B 0.00
VTv Therapeutics (VTVT) United States $0.042B 0.00
Rallybio (RLYB) United States $0.041B 0.00
Fortress Biotech (FBIO) United States $0.040B 0.00
Passage Bio (PASG) United States $0.040B 0.00
Clene (CLNN) United States $0.039B 0.00
OKYO Pharma (OKYO) $0.038B 0.00
CalciMedica (CALC) United States $0.038B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.037B 0.00
NextCure (NXTC) United States $0.037B 0.00
SAB Biotherapeutics (SABS) United States $0.036B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
Lumos Pharma (LUMO) United States $0.035B 0.00
Lexaria Bioscience (LEXX) Canada $0.035B 0.00
Dare Bioscience (DARE) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Elevation Oncology (ELEV) United States $0.033B 0.00
KALA BIO (KALA) United States $0.032B 0.00
Eyenovia (EYEN) United States $0.032B 0.00
Celularity (CELU) United States $0.032B 0.00
Dyadic (DYAI) United States $0.031B 0.00
Longeveron (LGVN) United States $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
Opus Genetics (IRD) United States $0.031B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.031B 0.00
Ocean Biomedical (OCEA) United States $0.030B 0.00
Aligos Therapeutics (ALGS) United States $0.030B 0.00
BioXcel Therapeutics (BTAI) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Estrella Immunopharma (ESLA) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
Athira Pharma (ATHA) United States $0.027B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.027B 0.00
Equillium (EQ) United States $0.027B 0.00
Pluri (PLUR) Israel $0.026B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
BRIACELL THERAP (BCTX) Canada $0.025B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.025B 0.00
Curis (CRIS) United States $0.025B 0.00
RenovoRx (RNXT) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Beyond Air (XAIR) United States $0.023B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.023B 0.00
Spruce Biosciences (SPRB) United States $0.022B 0.00
Aprea Therapeutics (APRE) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
Cyclo Therapeutics (CYTH) United States $0.021B 0.00
Chemomab Therapeutics (CMMB) Israel $0.021B 0.00
LakeShore Biopharma (LSB) China $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
UNITY Biotechnology (UBX) United States $0.019B 0.00
BioAffinity Technologies (BIAF) United States $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
Cara Therapeutics (CARA) United States $0.017B 0.00
Cadrenal Therapeutics (CVKD) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
HCW Biologics (HCWB) United States $0.016B 0.00
Tenax Therapeutics (TENX) United States $0.016B 0.00
IN8bio (INAB) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
Evaxion Biotech (EVAX) Denmark $0.014B 0.00
Apollomics (APLM) United States $0.013B 0.00
Turnstone Biologics (TSBX) United States $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
COSCIENS Biopharma (CSCI) Canada $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Biora Therapeutics (BIOR) United States $0.010B 0.00
Evogene (EVGN) Israel $0.010B 0.00
Cingulate (CING) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Vincerx Pharma (VINC) United States $0.010B 0.00
NKGen Biotech (NKGN) United States $0.010B 0.00
Galecto (GLTO) Denmark $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Edesa Biotech (EDSA) Canada $0.009B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.009B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
TuHURA Biosciences (HURA) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Aptose Biosciences (APTO) Canada $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Forte Biosciences (FBRX) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Carmell (CTCX) United States $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Quantum Biopharma (QNTM) Canada $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Dogwood Therapeutics (DWTX) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Exicure (XCUR) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Psyence Biomedical (PBM) Canada $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Elevai Labs (ELAB) United States $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00